Northeastern's proof at the liability phase centered on the six types of conduct it alleged to be anticompetitive: pricing, advertising, marketing, introduction of new products, SNET's alleged use of its utility

82

*82function to impede competition, and appellants' design of the protective coupler. The presentation of this evidence and of appellants' proof in opposition required almost three weeks. When both sides finally rested, the jury was asked to respond to fourteen interrogatories. It returned a verdict for Northeastern on all four of the claims, finding that each of appellants' six challenged activities was anticompetitive. Upon presentation of further evidence on damages, the jury awarded appellee $5,515,692. Of this amount, $3,368,906 was for lost profits; $2,146,786 was for damage to Northeastern's "going concern value." Pursuant to Section 4 of the Clayton Act, 15 U.S.C. 15, the district court ordered that the amount be trebled, to the sum of $16,547,076.

Question 1

How should the body surface area be calculated when giving drugs for

which doses are given per square metre of body surface area?

Question 2

Where can I find a reference table that shows drugs that can safely be

prescribed and avoided during pregnancy and during lactation? Might

this be included in the next edition of Kumar and Clark's Clinical

Medicine?161

Question 3

Where might I find a reference table showing paediatric drug doses?

Question 4

My question is concerned with the practical use of steroids. In

inflammatory bowel disease, what doses are used and when is the dose

reduced?

Question 5

What is the safe dosage/length of treatment for the drug dexmethasone

so that its destructive effects are avoided?

Question 6

1. Please explain 'odds ratio' and 'risk ratio'.

2. What is meant by saying that diabetics have a 3.3 risk ratio of

developing dementia?

Question 7

I'm a medical student from the Faculty of Medicine, Peradeniya, Sri

Lanka. I have a question about the management of aspirin poisoning. Is it

reasonable to carry out a postalkaline diuresis in these patients?

Question 8

What is meant by intermediate syndrome in organophosphorus

poisoning?

Question 9

What are the pulmonary manifestations of Pink's disease and how

common are they relative to the usual cerebral, skin and renal

effects?

Question 10

Is it necessary to administer antivenom to a person bitten by a snake

6 hours previously, presenting only with local leg swelling over the bitten

site and so far no other systemic feature of poisoning?